Page last updated: 2024-08-26

propionylcarnitine and Obesity

propionylcarnitine has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auriola, S; Hanhineva, K; Huotari, A; Keski-Rahkonen, P; Kolehmainen, M; Lehtonen, M; Mykkänen, H; Olli, K; Pekkinen, J; Poutanen, K; Tiihonen, K1
Alvarez de Sotomayor, M; Dolores Herrera, M; Gonzalez del Pozo, M; Mingorance, C1

Other Studies

2 other study(ies) available for propionylcarnitine and Obesity

ArticleYear
Betaine supplementation causes increase in carnitine metabolites in the muscle and liver of mice fed a high-fat diet as studied by nontargeted LC-MS metabolomics approach.
    Molecular nutrition & food research, 2013, Volume: 57, Issue:11

    Topics: Acetylcarnitine; Adipose Tissue; Adiposity; Animals; Betaine; Blood Glucose; Carnitine; Chromatography, Liquid; Diet, High-Fat; Dietary Supplements; Fasting; Glucans; Insulin; Leptin; Lipid Metabolism; Liver; Male; Mass Spectrometry; Metabolomics; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Obesity; Triglycerides; Weight Gain

2013
Oral supplementation of propionyl-l-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats.
    The British journal of nutrition, 2009, Volume: 102, Issue:8

    Topics: Animals; Carnitine; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Endothelium, Vascular; Glucose Tolerance Test; Hemodynamics; Hyperinsulinism; Insulin Resistance; Lipids; Metabolic Syndrome; Obesity; Rats; Rats, Zucker; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Weight Gain

2009